A common simple protocol used in long-term laboratory studies is 3 mg of GHK-Cu per day ongoing, administered subcutaneously once daily on a continuous basis with weekends off
This method can be particularly beneficial for cancer patients, who often experience malnutrition, gastrointestinal issues, or impaired absorption due to chemotherapy, radiation, or aid in fighting the cancer itself
Junyu Zhao, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
At 425.110(a), we are finalizing our revision to paragraph (2) by adding the introductory phrase, For agreement periods beginning before January 1, 2027, to limit the timing of applicability of the provision
Its also important to be aware of possible side effects, such as ongoing nausea or serious injection-site reactions
